Skip to main content
. 2023 Aug 8;20(1):2243252. doi: 10.1080/15502783.2023.2243252

Figure 4.

Figure 4.

(a) Differences between treatment groups in the VR-12 PCS at baseline, 3 months, 6 months, and 9 months, with reported p-value for group by time interaction. (b) Differences between males in treatment groups in the VR-12 PCS at baseline, 3 months, 6 months, and 9 months. (c) Differences between females in treatment groups in the VR-12 PCS at baseline, 3 months, 6 months, and 9 months. AU = arbitrary units, g = grams, d = day, PCS = physical component score.